Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Yashoda Hospitals -Secunderabad

Verified

Basic Information

Site Overview

Source: Human-provided.

Yashoda Hospitals is a multi-specialty healthcare network that integrates advanced patient care with clinical research activities. The institution supports clinical studies and trials across multiple therapeutic areas by leveraging its high patient volume, specialized departments, and experienced medical teams. Through its research initiatives, Yashoda Hospitals contributes to evidence-based medicine, evaluation of new treatments, and improvement of clinical outcomes while maintaining strong standards of patient safety and ethical research practices.

Source: Trial-derived.
21Total Trials
Source: Trial-derived.
9Recruiting Trials
Source: Trial-derived.
16Active Trials
Source: Trial-derived.
4Completed Trials
Source: Trial-derived.
23Unique Conditions
Source: Trial-derived.
15Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Colitis, Ulcerative (3)Source: Trial-derived. Crohn's Disease (3)Source: Trial-derived. Inflammatory Bowel Diseases (2)Source: Trial-derived. Moderately to Severely Active Crohns Disease (2)Source: Trial-derived. Acute Ischemic Stroke (1)Source: Trial-derived. Acute Kidney Injury (1)Source: Trial-derived. Acute-On-Chronic Liver Failure (1)Source: Trial-derived. Atrial Fibrillation (1)

Sponsors

Source: Trial-derived. Janssen Research & Development, LLC (4)Source: Trial-derived. Boehringer Ingelheim (3)Source: Trial-derived. Hoffmann-La Roche (3)Source: Trial-derived. Bristol-Myers Squibb (2)Source: Trial-derived. Chugai Pharmaceutical (2)Source: Trial-derived. Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) (2)Source: Trial-derived. Eli Lilly and Company (1)Source: Trial-derived. European Foundation for Study of Chronic Liver Failure (1)

Trial Phases

Historical Trial Phase Experience

Source: Human-provided. Phase II
Source: Human-provided. Phase III
Source: Human-provided. Phase IV

Research Team & Staffing

Research team size (total staff)

Source: Human-provided. 21

Principal investigators

Source: Human-provided. 10

Study coordinators

Source: Human-provided. 6

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)
Source: AI-inferred. MRI proton density fat fraction

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Liver biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom
Source: Google. Wheelchair accessible seating

Amenities

Amenities Available

Source: Google. Gender-neutral restroom
Source: Google. Nursing room

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Enhanced liver fibrosis testing
Source: AI-inferred. Magnetic resonance elastography